The conditions for the production of histamine releasing factor (HRF) by guinea-pig spleen cells, thymocytes, and PBMC were investigated. Cultures of lymphoid cells were studied either alone or in the presence of mitogens or specific antigen (Ag) and the dialyzed cell free supernatant was tested for histamine releasing activity on English-short-hair-guinea-pig lung mast cells and blood basophils. Significant amounts of HRF were produced by guinea-pig spleen cells, thymocytes, and PBMC spontaneously while in animals immunized with Ag in CFA the production was enhanced on stimulation with phytohemagglutinin or specific Ag. Gel chromatography identified two distinct species of HRF with molecular weights of 50,000 to 70,000 and 5000 to 8000. The histamine release from lung mast cells as induced by HRF was temperature dependent and complete in 10 minutes at 37 degrees-C. An immediate ear swelling reaction was noted in guinea pigs following the intradermal injection of HRF. The most severe of these reactions was sustained over a period of 12 to 24 hours when higher doses of HRF were administered. These results suggest that guinea-pig lymphocytes can produce HRF that releases histamine from mast cell and basophils. HRF was active in- vivo. The intradermal injection of gel fractionated HRF induced an immediate ear swelling reaction. Gel fractionated HRF had no IL-1 activity. The guinea-pig mast cells released relatively small amounts of histamine, 8 to 20 percent, compared to the 30 percent of so released by the basophils. The authors conclude that the guinea- pig is a good model for various diseases.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.